GlobeNewswire Inc.··Prf Technologies Ltd.PRF Technologies Advances OcuRing™-K Toward Phase II Trial With FDA IND Clearance
PRF Technologies gains FDA clearance for OcuRing™-K, a bio-erodible intraocular ring delivering ketorolac post-surgery, with Phase II trials beginning mid-2026.
PRFXcataract surgeryPhase II clinical trial